In one paragraphArticle in Genes & development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
9 authors.
Neuza R MatiasDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA.ORCID 0000-0003-1548-037X Lorenzo GallicchioDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA.ORCID 0000-0002-5040-0139 Dan LuDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA.ORCID 0000-0002-7492-3954 Jongmin J KimDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, California 94305, USA.ORCID 0000-0002-1836-2064 Julian PerezDepartment of Genetics, Stanford University School of Medicine, Stanford, California 94305, USA.ORCID 0000-0003-0022-9967 Chenggang LuDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA.
Benjamin BolivalDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA.ORCID 0000-0001-5734-5112 Margaret T FullerDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA; mtfuller@stanford.edu.ORCID 0000-0002-3804-4987 Funding
Regulation of proliferation and differentiation in the male germ line adult stem cell lineageR35GM136433 · NIGMS · STANFORD UNIVERSITY · PI MARGARET T FULLER · 2020 to 2026
$5.9MRegulation of Spermatocyte Transcription by Testis TAFSR01GM061986 · NIGMS · STANFORD UNIVERSITY · PI FULLER, MARGARET T · 2000 to 2017
$5.1MGenetics and Developmental Biology Training ProgramT32GM141828 · NIGMS · STANFORD UNIVERSITY · PI MARGARET T FULLER, Gavin J Sherlock · 2022 to 2026
$2.6MChromatin dynamics, transcriptional activators and repressors in transition from proliferating progenitors to terminal differentiation during adult stem cell differentiationF32HD086986 · NICHD · STANFORD UNIVERSITY · PI LU, DAN · 2016 to 2018
$173kNICHD NIH HHS F32 HD086986NIGMS NIH HHS R01 GM061986NIGMS NIH HHS R35 GM136433NIGMS NIH HHS T32 GM141828
6 · The paper itselfAbstract
Regulators of chromatin accessibility play key roles in cell fate transitions, triggering the onset of novel transcription programs as cells differentiate. In the
Indexed as
Adult Stem CellsCell DifferentiationCell LineageDrosophila melanogasterDrosophila ProteinsPromoter Regions, GeneticAnimalsDNA-Binding ProteinsGene Expression Regulation, DevelopmentalMaleProtein BindingTranscription FactorsDNA-Binding ProteinsDrosophila ProteinsTranscription Factorschromatin regulationcryptic promotersDrosophilaNuRD complexspermatogenesistranscriptional repression
Identifiers
PMID40769719
PMCPMC12333557
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390